Spirit Scientific Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	273.29	226.39	178.86	123.34
Revenue Growth (YoY)	20.71%	26.57%	45.02%	-
Cost of Revenue	54.43	41.63	33.31	23.4
Gross Profit	218.86	184.77	145.55	99.94
Selling, General & Admin	175.8	154.48	120.99	82.23
Research & Development	20.74	22.35	15.38	10.32
Operating Expenses	196.47	176.45	137.05	92.56
Operating Income	22.38	8.32	8.5	7.38
Interest Expense	-1	-0.79	-0.91	-1.03
Interest & Investment Income	2.81	1.86	0.44	0.13
Currency Exchange Gain (Loss)	-	-0.18	0.08	-
Other Non Operating Income (Expenses)	1.83	0.57	0.08	-0.31
EBT Excluding Unusual Items	26.02	9.78	8.19	6.17
Gain (Loss) on Sale of Investments	-	-0.02	-	-
Pretax Income	26.02	9.76	8.19	6.17
Income Tax Expense	5.96	4.71	3.15	0.14
Net Income	20.06	5.05	5.04	6.03
Net Income to Common	20.06	5.05	5.04	6.03
Net Income Growth	296.99%	0.20%	-16.41%	-
Shares Outstanding (Basic)	18	17	14	13
Shares Outstanding (Diluted)	18	17	14	13
Shares Change (YoY)	5.16%	24.00%	4.61%	-
EPS (Basic)	1.14	0.30	0.37	0.46
EPS (Diluted)	1.13	0.30	0.37	0.46
EPS Growth	276.67%	-19.39%	-19.72%	-
Free Cash Flow	43.68	-40.23	12.36	14.75
Free Cash Flow Per Share	2.46	-2.38	0.91	1.13
Dividend Per Share	0.600	0.069	0.271	-
Dividend Growth	769.56%	-74.50%	-	-
Gross Margin	80.08%	81.61%	81.38%	81.03%
Operating Margin	8.19%	3.67%	4.75%	5.99%
Profit Margin	7.34%	2.23%	2.82%	4.89%
Free Cash Flow Margin	15.98%	-17.77%	6.91%	11.96%
EBITDA	51.71	19.38	16.56	23.79
EBITDA Margin	18.92%	8.56%	9.26%	19.29%
D&A For EBITDA	29.33	11.06	8.06	16.41
EBIT	22.38	8.32	8.5	7.38
EBIT Margin	8.19%	3.67%	4.75%	5.99%
Effective Tax Rate	22.91%	48.23%	38.42%	2.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.